Kapiva Launches INR 50 Cr Fund To Back Ayurveda Research

D2C ayurveda brand Kapiva has launched a INR 50 Cr innovation fund to support research and product development in Ayurveda.

The fund is open for applications from today and will back projects from research institutions, PhD scholars, hospitals, labs and startups. The startup said that the money will be used to support ayurvedic research, new product development, and the use of AI in Ayurveda.

The focus of the fund will be on building clinically tested solutions for real health problems. Along with funding, Kapiva will offer access to its in-house experts and expand its R&D facility in Bengaluru.

The startup will invest around INR 50 Lakh in early-stage research projects, while late-stage research projects could attract investments in the range of INR 4-6 Cr.

The startup said many researchers and startups want to build better ayurvedic products but lack the resources to do so.

It is pertinent to mention that the D2C startup has raised around $120 Mn in funding to date. It last raised $60 Mn (INR 532 Cr) in a Series D round back in September 2025. Kapiva cofounder Ameeve Sharma said that the capital earmarked for the fund is from its last fundraise. 

Founded in 2016 by Sharma and Shrey Badhani, Kapiva sells ayurvedic nutrition and wellness products across categories like supplements, gummies, capsules and skincare. It has over 100 products and also offers consultations with ayurvedic doctors. 

The startup’s top categories include diabetes care, gym and sports nutrition, energy, and liver and heart health.Kapiva sells its products through its own D2C website, online marketplaces and offline retail stores. Sharma has said the diabetes supplement category is the brand’s highest-selling segment.

Kapiva’s move comes at a time when demand for natural and herbal wellness products is rising in India. The ayurvedic products market in India is expected to grow to INR 3.21 Lakh Cr by 2032, growing at a CAGR of 17%.

However, the space is getting crowded. D2C brands such as OZiva, Himalayan Organics and The Ayurveda Co are competing for market share, while large FMCG players like Dabur, Himalaya and Patanjali are also increasing their focus on ayurvedic and herbal products.

Kapiva plans to go public in the next two to three years.

The post Kapiva Launches INR 50 Cr Fund To Back Ayurveda Research appeared first on Inc42 Media.